Geode Capital Management
BDSI

Geode Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Geode Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,724,411
Closed -$5.34M – 5089
2021
Q4 		$5.34M Sell
1,724,411
-24,223
-1% -$81.5K ﹤0.01% 2862
2021
Q3 		$6.31M Buy
1,748,634
+81,687
+5% +$308K ﹤0.01% 2778
2021
Q2 		$5.97M Buy
1,666,947
+43,689
+3% +$154K ﹤0.01% 2797
2021
Q1 		$6.35M Buy
1,623,258
+260,176
+19% +$1.07M ﹤0.01% 2664
2020
Q4 		$5.72M Buy
1,363,082
+35,516
+3% +$137K ﹤0.01% 2531
2020
Q3 		$4.95M Buy
1,327,566
+50,739
+4% +$216K ﹤0.01% 2405
2020
Q2 		$5.57M Buy
1,276,827
+97,328
+8% +$437K ﹤0.01% 2280
2020
Q1 		$4.47M Buy
1,179,499
+54,545
+5% +$268K ﹤0.01% 2212
2019
Q4 		$7.11M Buy
1,124,954
+122,110
+12% +$718K ﹤0.01% 2241
2019
Q3 		$4.22M Buy
1,002,844
+16,011
+2% +$68.4K ﹤0.01% 2477
2019
Q2 		$4.59M Buy
986,833
+447,455
+83% +$2.08M ﹤0.01% 2455
2019
Q1 		$2.86M Buy
539,378
+21,758
+4% +$99.4K ﹤0.01% 2636
2018
Q4 		$1.92M Buy
517,620
+5,628
+1% +$19.8K ﹤0.01% 2802
2018
Q3 		$1.43M Buy
511,992
+11,651
+2% +$32.7K ﹤0.01% 3063
2018
Q2 		$1.48M Buy
500,341
+37,808
+8% +$89.7K ﹤0.01% 3017
2018
Q1 		$1.04M Hold
462,533
– – ﹤0.01% 3102
2017
Q4 		$1.36M Hold
462,533
– – ﹤0.01% 2966
2017
Q3 		$1.36M Hold
462,533
– – ﹤0.01% 2977
2017
Q2 		$1.29M Sell
462,533
-8,193
-2% -$17.3K ﹤0.01% 2984
2017
Q1 		$894K Buy
470,726
+658
+0.1% +$1.27K ﹤0.01% 3073
2016
Q4 		$822K Buy
470,068
+145,576
+45% +$297K ﹤0.01% 3086
2016
Q3 		$876K Buy
324,492
+20,169
+7% +$51.2K ﹤0.01% 3009
2016
Q2 		$717K Buy
304,323
+4,540
+2% +$12.5K ﹤0.01% 3055
2016
Q1 		$968 Buy
299,783
+3,067
+1% +$11.3K ﹤0.01% 2897
2015
Q4 		$1.42M Buy
296,716
+6,111
+2% +$34.6K ﹤0.01% 2695
2015
Q3 		$1.61M Buy
290,605
+29,071
+11% +$215K ﹤0.01% 2576
2015
Q2 		$2.08M Buy
261,534
+6,524
+3% +$56.1K ﹤0.01% 2478
2015
Q1 		$2.68M Buy
255,010
+13,117
+5% +$179K ﹤0.01% 2258
2014
Q4 		$2.91M Buy
241,893
+9,751
+4% +$148K ﹤0.01% 2178
2014
Q3 		$3.97M Buy
232,142
+15,171
+7% +$220K ﹤0.01% 1908
2014
Q2 		$2.62M Buy
216,971
+7,547
+4% +$71.6K ﹤0.01% 2208
2014
Q1 		$1.77M Buy
209,424
+93,716
+81% +$756K ﹤0.01% 2411
2013
Q4 		$681K Buy
115,708
+1,775
+2% +$9.15K ﹤0.01% 2927
2013
Q3 		$619K Buy
113,933
+3,438
+3% +$16.5K ﹤0.01% 2838
2013
Q2 		$449K Buy
+110,495
New +$519K ﹤0.01% 2940

Other funds holding BDSI

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return
FCMT
Founders Capital Management (Texas) Houston, Texas $205M AUM 41.7% 1-Year Est. Return

Geode Capital Management's BDSI Position: Q1 2022 in Review

Geode Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 1,724,411 shares — an estimated $5.34M sold.

Geode Capital Management first reported a position in BDSI in Q2 2013 and held it in 35 quarters. The position peaked at $7.11M in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Geode Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Geode Capital Management sold 1,724,411 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $5.34M.
  • Geode Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 35 quarters.
  • Geode Capital Management's BioDelivery Sciences International, Inc. position peaked at $7.11M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Geode Capital Management's 13F filing for Q1 2022, filed 13 May 2022.